المؤلفون: Bruera E., Hui D., Bush S.H., Gallo L.E., Palmer J.L., Yennurajalingam S.

مصطلحات الفهرس: haloperidol/pa [Parenteral Drug Administration], add on therapy, adult, advanced cancer, aged, agitation, article, cancer patient, caregiver, correlation analysis, correlational study, delirium/dt [Drug Therapy], delirium/th [Therapy], distress syndrome, drug efficacy, drug use, female, health care personnel, human, job stress, major clinical study, male, medical record, medical specialist, nurse, palliative therapy, retrospective study, statistical significance, symptom, chlorpromazine/dt [Drug Therapy], chlorpromazine/pa [Parenteral Drug Administration], haloperidol/dt [Drug Therapy], haloperidol/iv [Intravenous Drug Administration], haloperidol/po [Oral Drug Administration], lorazepam/dt [Drug Therapy], midazolam/dt [Drug Therapy], neuroleptic agent/do [Drug Dose], neuroleptic agent/dt [Drug Therapy], olanzapine/dt [Drug Therapy], olanzapine/po [Oral Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31044
Click here for full text options
LibKey Link

المؤلفون: Horne M.K., Parish C.L., Stanic D., Drago J., Borrelli E., Finkelstein D.I.

مصطلحات الفهرس: animal tissue, article, cell size, controlled study, corpus striatum, drug effect, long term care, male, mouse, nerve ending, nonhuman, priority journal, rat, sprouting, substantia nigra, animal experiment, 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/pd [Pharmacology], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/ip [Intraperitoneal Drug Administration], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/pd [Pharmacology], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/ip [Intraperitoneal Drug Administration], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/pd [Pharmacology], benserazide plus levodopa/po [Oral Drug Administration], benserazide plus levodopa/pd [Pharmacology], bromocriptine/ip [Intraperitoneal Drug Administration], bromocriptine/pd [Pharmacology], cocaine/ip [Intraperitoneal Drug Administration], cocaine/pd [Pharmacology], cocaine/sc [Subcutaneous Drug Administration], dopamine 2 receptor blocking agent/pd [Pharmacology], dopamine 2 receptor stimulating agent/pd [Pharmacology], dopamine receptor blocking agent/po [Oral Drug Administration], dopamine receptor blocking agent/pd [Pharmacology], dopamine receptor stimulating agent/ip [Intraperitoneal Drug Administration], dopamine receptor stimulating agent/pd [Pharmacology], dopamine receptor stimulating agent/sc [Subcutaneous Drug Administration], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], sulpiride/ip [Intraperitoneal Drug Administration], sulpiride/pd [Pharmacology], 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/ip [Intraperitoneal Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33106
Click here for full text options
LibKey Link

المؤلفون: Stanic D., Borrelli E., Parish C.L., Drago J., Horne M.K., Finkelstein D.I.

مصطلحات الفهرس: statistical significance, stereology, synaptogenesis, cocaine, dopamine 2 receptor blocking agent/do [Drug Dose], dopamine 2 receptor blocking agent/po [Oral Drug Administration], dopamine 2 receptor blocking agent/pd [Pharmacology], haloperidol/do [Drug Dose], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], nonhuman, animal cell, animal experiment, animal model, animal tissue, article, behavior, cell size, cocaine dependence, controlled study, corpus striatum, dopaminergic activity, high performance liquid chromatography, innervation, male, mouse, nerve cell, priority journal, relapse, Article

URL: Click here for full text options
LibKey Link

المؤلفون: Pavey G., Copolov D.L., Dean B., Hussain T., Scarr E.

مصطلحات الفهرس: drug effect, drug receptor binding, ligand binding, male, nonhuman, psychosis/dt [Drug Therapy], rat, receptor density, 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 4 aminobutyric acid A receptor/ec [Endogenous Compound], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate, chlorpromazine/cm [Drug Comparison], chlorpromazine/do [Drug Dose], chlorpromazine/dt [Drug Therapy], chlorpromazine/po [Oral Drug Administration], chlorpromazine/pd [Pharmacology], clozapine/cm [Drug Comparison], clozapine/do [Drug Dose], clozapine/dt [Drug Therapy], clozapine/po [Oral Drug Administration], clozapine/pd [Pharmacology], dopamine 2 receptor/ec [Endogenous Compound], emonapride, haloperidol/cm [Drug Comparison], haloperidol/do [Drug Dose], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], muscimol, olanzapine/pd [Pharmacology], radioligand, tritium, haloperidol/dt [Drug Therapy], olanzapine/po [Oral Drug Administration], neuroleptic agent/cm [Drug Comparison], neuroleptic agent/do [Drug Dose], neuroleptic agent/dt [Drug Therapy], neuroleptic agent/po [Oral Drug Administration], neuroleptic agent/pd [Pharmacology], olanzapine/cm [Drug Comparison], olanzapine/do [Drug Dose], olanzapine/dt [Drug Therapy], animal experiment, animal model, animal tissue, article, brain nerve cell, controlled study, corpus striatum, dose time effect relation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33203
Click here for full text options
LibKey Link

المؤلفون: Bruera E., Hui D., Bush S.H., Gallo L.E., Palmer J.L., Yennurajalingam S.

مصطلحات الفهرس: haloperidol/pa [Parenteral Drug Administration], add on therapy, adult, advanced cancer, aged, agitation, article, cancer patient, caregiver, correlation analysis, correlational study, delirium/dt [Drug Therapy], delirium/th [Therapy], distress syndrome, drug efficacy, drug use, female, health care personnel, human, job stress, major clinical study, male, medical record, medical specialist, nurse, palliative therapy, retrospective study, statistical significance, symptom, chlorpromazine/dt [Drug Therapy], chlorpromazine/pa [Parenteral Drug Administration], haloperidol/dt [Drug Therapy], haloperidol/iv [Intravenous Drug Administration], haloperidol/po [Oral Drug Administration], lorazepam/dt [Drug Therapy], midazolam/dt [Drug Therapy], neuroleptic agent/do [Drug Dose], neuroleptic agent/dt [Drug Therapy], olanzapine/dt [Drug Therapy], olanzapine/po [Oral Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31044
LibKey Link

المؤلفون: Horne M.K., Parish C.L., Stanic D., Drago J., Borrelli E., Finkelstein D.I.

مصطلحات الفهرس: animal tissue, article, cell size, controlled study, corpus striatum, drug effect, long term care, male, mouse, nerve ending, nonhuman, priority journal, rat, sprouting, substantia nigra, animal experiment, 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/pd [Pharmacology], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/ip [Intraperitoneal Drug Administration], 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine/pd [Pharmacology], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/ip [Intraperitoneal Drug Administration], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate/pd [Pharmacology], benserazide plus levodopa/po [Oral Drug Administration], benserazide plus levodopa/pd [Pharmacology], bromocriptine/ip [Intraperitoneal Drug Administration], bromocriptine/pd [Pharmacology], cocaine/ip [Intraperitoneal Drug Administration], cocaine/pd [Pharmacology], cocaine/sc [Subcutaneous Drug Administration], dopamine 2 receptor blocking agent/pd [Pharmacology], dopamine 2 receptor stimulating agent/pd [Pharmacology], dopamine receptor blocking agent/po [Oral Drug Administration], dopamine receptor blocking agent/pd [Pharmacology], dopamine receptor stimulating agent/ip [Intraperitoneal Drug Administration], dopamine receptor stimulating agent/pd [Pharmacology], dopamine receptor stimulating agent/sc [Subcutaneous Drug Administration], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], sulpiride/ip [Intraperitoneal Drug Administration], sulpiride/pd [Pharmacology], 2 ethoxy 1(2h) quinolinecarboxylic acid ethyl ester/ip [Intraperitoneal Drug Administration], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33106
LibKey Link

المؤلفون: Stanic D., Borrelli E., Parish C.L., Drago J., Horne M.K., Finkelstein D.I.

مصطلحات الفهرس: statistical significance, stereology, synaptogenesis, cocaine, dopamine 2 receptor blocking agent/do [Drug Dose], dopamine 2 receptor blocking agent/po [Oral Drug Administration], dopamine 2 receptor blocking agent/pd [Pharmacology], haloperidol/do [Drug Dose], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], nonhuman, animal cell, animal experiment, animal model, animal tissue, article, behavior, cell size, cocaine dependence, controlled study, corpus striatum, dopaminergic activity, high performance liquid chromatography, innervation, male, mouse, nerve cell, priority journal, relapse, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32198
LibKey Link

المؤلفون: Pavey G., Copolov D.L., Dean B., Hussain T., Scarr E.

مصطلحات الفهرس: drug effect, drug receptor binding, ligand binding, male, nonhuman, psychosis/dt [Drug Therapy], rat, receptor density, 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 4 aminobutyric acid A receptor/ec [Endogenous Compound], 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate, chlorpromazine/cm [Drug Comparison], chlorpromazine/do [Drug Dose], chlorpromazine/dt [Drug Therapy], chlorpromazine/po [Oral Drug Administration], chlorpromazine/pd [Pharmacology], clozapine/cm [Drug Comparison], clozapine/do [Drug Dose], clozapine/dt [Drug Therapy], clozapine/po [Oral Drug Administration], clozapine/pd [Pharmacology], dopamine 2 receptor/ec [Endogenous Compound], emonapride, haloperidol/cm [Drug Comparison], haloperidol/do [Drug Dose], haloperidol/po [Oral Drug Administration], haloperidol/pd [Pharmacology], muscimol, olanzapine/pd [Pharmacology], radioligand, tritium, haloperidol/dt [Drug Therapy], olanzapine/po [Oral Drug Administration], neuroleptic agent/cm [Drug Comparison], neuroleptic agent/do [Drug Dose], neuroleptic agent/dt [Drug Therapy], neuroleptic agent/po [Oral Drug Administration], neuroleptic agent/pd [Pharmacology], olanzapine/cm [Drug Comparison], olanzapine/do [Drug Dose], olanzapine/dt [Drug Therapy], animal experiment, animal model, animal tissue, article, brain nerve cell, controlled study, corpus striatum, dose time effect relation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33203
LibKey Link